Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
5.18
+0.15 (2.98%)
At close: Mar 17, 2026, 4:00 PM EDT
5.26
+0.08 (1.54%)
Pre-market: Mar 18, 2026, 8:00 AM EDT
Bausch Health Companies Revenue
In the year 2025, Bausch Health Companies had annual revenue of $10.27B with 6.66% growth. Bausch Health Companies had revenue of $4.90B in the quarter ending December 31, 2025, with 91.53% growth.
Revenue (ttm)
$11.62B
Revenue Growth
+29.49%
P/S Ratio
0.19
Revenue / Employee
$505,714
Employees
20,300
Market Cap
1.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.27B | 641.00M | 6.66% |
| Dec 31, 2024 | 9.63B | 868.00M | 9.91% |
| Dec 31, 2023 | 8.76B | 633.00M | 7.79% |
| Dec 31, 2022 | 8.12B | -310.00M | -3.68% |
| Dec 31, 2021 | 8.43B | 407.00M | 5.07% |
| Dec 31, 2020 | 8.03B | -574.00M | -6.67% |
| Dec 31, 2019 | 8.60B | 221.00M | 2.64% |
| Dec 31, 2018 | 8.38B | -344.00M | -3.94% |
| Dec 31, 2017 | 8.72B | -950.00M | -9.82% |
| Dec 31, 2016 | 9.67B | -773.00M | -7.40% |
| Dec 31, 2015 | 10.45B | 2.24B | 27.31% |
| Dec 31, 2014 | 8.21B | 2.44B | 42.23% |
| Dec 31, 2013 | 5.77B | 2.29B | 65.77% |
| Dec 31, 2012 | 3.48B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Perrigo Company | 4.25B |
| Phibro Animal Health | 1.46B |
| Prestige Consumer Healthcare | 1.10B |
| ANI Pharmaceuticals | 883.37M |
| BioCryst Pharmaceuticals | 874.84M |
| Collegium Pharmaceutical | 780.57M |
| Supernus Pharmaceuticals | 718.95M |
| Alvotech | 573.35M |
BHC News
- 22 days ago - Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada - PRNewsWire
- 26 days ago - Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres - PRNewsWire
- 27 days ago - BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS - PRNewsWire
- 4 weeks ago - Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference - PRNewsWire
- 4 weeks ago - Bausch Health Announces 2026 Gastrointestinal Health Scholars Program - PRNewsWire
- 7 weeks ago - Bausch Health's brain dysfunction treatment fails late-stage trial - Reuters
- 7 weeks ago - Bausch Health Provides Update on RED-C Phase 3 Clinical Trials - PRNewsWire
- 2 months ago - Bausch Health to Announce Fourth Quarter and Full Year 2025 Results on February 18, 2026 - PRNewsWire